Clinical Trial Update: Efficacy of Daptomycin Plus Fosfomycin Versus Daptomycin for Treatment of MRSA Bacteremia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing daptomycin plus fosfomycin versus daptomycin alone for MRSA bacteremia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcus Aureus Methicillin-resistant Bacteremia

Drugs mentioned

• Daptomycin (daptomycin)
• Fosfomycin (Fosfomycin)

Snippet

Sponsor: Miquel Pujol | Conditions: Staph Aureus Methicillin Resistant Bacteremia | Phase 3 | Status: COMPLETED